Skip to main content

Table 1 Demographic data and clinical characteristics of the schizophrenic group with a high SANS score, the schizophrenic group with a low SANS score, and the control group as well as significance of results

From: Neuropsychological and cerebral morphometric aspects of negative symptoms in schizophrenia: negative symptomatology is associated with specific mnestic deficits in schizophrenic patients

Demographic data/clinical characteristics

Schizophrenics high SANS-score

Schizophrenics low SANS-score

Controls

 
 

Mean

SD

Mean

SD

Mean

SD

F-value

Age (in years)

27,90

6,03

30,40

7,78

28,22

5,83

0,53

School education (in years)

12,30

1,25

12,20

1,32

12,13

1,50

0,06

Sex (female/male)

7/3

 

5/5

 

22/10

 

1,301

Age of onset of clinical symptoms (in years)

24,22

3,80

26,10

6,06

  

0,63

Duration of schizophrenia (in months)

49,78

54,48

58,90

51,31

  

0,03

Number of psychotic episodes

2,11

2,42

2,00

2,00

  

0,30

Total amount of time hospitalized for schizophrenia (in weeks)

19,11

19,66

24,80

27,77

  

0,01

BPRS

45,50

16,86

27,60

8,57

  

7,36**

Positive family history for psychiatric disorders in 1st and 2nd grade dependant

8

 

10

   

4,21

Chlorpromazine-equivalents

10

 

10

   

0,81

  1. 1Pearson’s Chi-Square.
  2. (Spearman rank correlation, * p ≤0,05, ** p ≤0,01).